Preventing POAF after heart surgery with posterior pericardiotomy
Official title: Pericardiotomy for Prevention of Postoperative Atrial Fibrillation After Cardiac Surgery in China
Run by Changhai Hospital · NCT06728826 · Data updated 2026-11-12
This trial tests whether posterior pericardiotomy during cardiac surgery can reduce new atrial fibrillation after surgery in adults in China.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 650 (estimated) |
| Sponsor | Changhai Hospital Academic / other |
| Locations | 1 site (Shanghai) |
| Status | Recruiting |
| Started | December 1, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | June 30, 2027 |
| Registry record updated | July 14, 2026 |
| Trial ID | NCT06728826 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older undergoing surgery on proximal aorta, cardiac valves, or coronary arteries without a prior history of atrial fibrillation.
✕Probably not a fit
Patients with prior atrial fibrillation, certain complex procedures, or contraindications to pericardiotomy may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
PRINCE-CH is a multicenter randomized trial comparing posterior pericardiotomy to no posterior pericardiotomy in adults undergoing cardiac surgery in China. The primary outcome is the occurrence of postoperative atrial fibrillation, monitored with wearable ECG. The study aims to determine the safety and effectiveness of this surgical approach and its potential impact on recovery and resource use. Enrollment targets 650 participants across 15 centers, with continuous ECG monitoring during the postoperative period.
Why it matters
Potential benefit: If successful, patients may have a lower risk of POAF, potentially reducing complications and hospital stays.
How similar studies have gone: Earlier data suggest posterior pericardiotomy may reduce POAF, but definitive, long-term outcomes require this trial's results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients older than or equal to 18 years of age * Requiring surgical intervention on proximal aorta, cardiac valves, and/or coronary arteries * Able to provide informed consent Exclusion Criteria: * History of atrial fibrillation or flutter * Reoperations/minimally invasive cardiac surgery/emergent presentation * Need for hypothermic circulatory arrest * Disease of the left pleura or previous left thoracotomy * Chest deformity * Unlikely to participate in follow-up assessments
Where it's running
-
Changhai Hospital
Shanghai, China Recruiting
Study contacts
- Principal investigator: Hao Zhang, M.D. Ph.D. — Naval Medical University Changhai Hospital
- Study coordinator: Hao Zhang, M.D. Ph.D.
- Email: 13818178916@163.com
- Phone: 86-21-31161765
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pulsed Field vs Cryoballoon for Pulmonary Vein Isolation in Atrial Fibrillation
This trial tests whether pulsed field ablation can shorten the procedure for first-time PVI in AF patients compared with cryoballoon ablation, while keeping safety and effectiveness similar.
-
Pulsed Field Ablation vs Cryoablation for Atrial Fibrillation Under Deep Sedation
This trial tests whether pulsed field ablation (PFA) done under deep sedation works as well as cryoballoon ablation for treating atrial fibrillation, aiming to avoid general anesthesia.
-
Bachmann’s Bundle Pacing vs Right Atrial Appendage Pacing for AF
This study tests two common atrial pacing methods to see which one is safer over 12 months for people getting a new pacemaker, ICD, or CRT device.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Pace-and-ablate strategy in atrial fibrillation: who benefits and long-term outcomes
This study looks at adults with atrial fibrillation who underwent AV node ablation with permanent pacing to see who develops pacing-induced problems and how they do long-term.
-
AI-based cardiac analysis using 12-lead and 1-lead ECG
A clinician-facing pilot test to see if SmartECG-EF helps evaluate heart function using both 12-lead and single-lead ECGs in adults with heart conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.